Internalization of Bacille Calmette-Guerin by Bladder Tumor Cells

1991 ◽  
Vol 145 (6) ◽  
pp. 1316-1324 ◽  
Author(s):  
Michael J. Becich ◽  
Shirley Carroll ◽  
Timothy L. Ratliff
2006 ◽  
Vol 4 (12) ◽  
pp. 51
Author(s):  
B.-H. Lee ◽  
H.-Y. Hong ◽  
S.-J. Oh ◽  
E.-J. Lee ◽  
K. Wan ◽  
...  

2019 ◽  
Vol 21 (6) ◽  
pp. 331-338 ◽  
Author(s):  
Tao Wang ◽  
Xi Yu ◽  
Jian Lin ◽  
Cong Qin ◽  
Tao Bai ◽  
...  

1987 ◽  
Vol 138 (5) ◽  
pp. 1318-1320 ◽  
Author(s):  
W.B. Gill ◽  
A. Taja ◽  
D.M. Chadbourne ◽  
M. Roma ◽  
C.W. Vermeulen

1988 ◽  
Vol 140 (3) ◽  
pp. 672-677 ◽  
Author(s):  
Chi-Wei Lin ◽  
Deborah A. Young ◽  
Sandra D. Kirley ◽  
Aii-Hwa Khaw ◽  
George R. Prout

1980 ◽  
Vol 152 (1) ◽  
pp. 183-197 ◽  
Author(s):  
C Nathan ◽  
L Brukner ◽  
G Kaplan ◽  
J Unkeless ◽  
Z Cohn

Treatment of mice with Bacille Calmette-Guérin (BCG) or C parvum activates their peritoneal macrophages to release increased amounts of H2O2, and thereby to lyse extracellular tumor cells, in response to a pharmacologic agent, phorbol myristate acetate (PMA) (1-3). In the present study, the same bacterial vaccines activated peritoneal cells to become cytolytic to lymphoma cells sensitized with alloantiserum, in the absence of PMA. Resident peritoneal cells, or those elicited with thioglycollate broth, were ineffective, not only in PMA-induced lysis, but also in antibody-dependent lysis of tumor cells. The cytolytic effect of BCG peritoneal cells toward sensitized tumor cells appeared to be mediated mostly by macrophages. Cytotoxicity was immunologically specific, contact dependent, rapid, and efficient. Phagocytosis of intact tumor cells was not involved. Alloantiserum-dependent cytolysis was specifically blocked by the Fab fragment of a monoclonal antibody directed against the trypsin-resistant macrophage Fc receptor (FcR II). Thus, tumor cells coated with homologous immunoglobulin interact with FcR II on activated macrophages to trigger an extra-cellular cytolytic response.


2015 ◽  
Vol 95 (1) ◽  
pp. 1-8 ◽  
Author(s):  
Chao Chen ◽  
Xiang Jie Qi ◽  
Yan Wei Cao ◽  
Yong Hua Wang ◽  
Xue Cheng Yang ◽  
...  

Bladder cancer relapse and treatment failure in most patients have often been attributed to chemoresistance in tumor cells and metastasis. Emerging evidence indicates that tumor heterogeneity may play an equally important role and extends to virtually all measurable properties of cancer cells. Although the idea of tumor heterogeneity is not new, little attention has been paid to applying it to understand and control bladder cancer progression. With the development of biotechnology, such as Gene sequencing, recent advances in understanding its generation model, original basis, consequent problems, and derived therapies provide great potential for tumor heterogeneity to be considered a new insight in the treatment of bladder cancers.


Planta Medica ◽  
2005 ◽  
Vol 71 (11) ◽  
pp. 1030-1035 ◽  
Author(s):  
Dimitris Skalkos ◽  
Nikolaos Stavropoulos ◽  
Ioannis Tsimaris ◽  
Eleni Gioti ◽  
Constantine Stalikas ◽  
...  

1987 ◽  
Vol 137 (6) ◽  
Author(s):  
Jeannine P. Alexander ◽  
Paul F. Schellhammer ◽  
Alice M. Konchuba ◽  
George L. Wright

Sign in / Sign up

Export Citation Format

Share Document